Can Automation Improve Compliance, Consistency, & Efficiency for CGTP Data Analysis. With the promise of treating cancer, Parkinson’s, and other rare diseases, cell and gene therapy products (CGTPs) are gaining traction in the biopharma industry. As of 2023, the FDA has approved 34 CGTPs and over 1500 clinical trials are currently ongoing globally. Despite the increasing number of CGTP drug candidates, the bioanalysis supporting these programs is still fraught with many hurdles. Learn more in this app note.
Posters
0